Millipore Sigma Vibrant Logo
Atención: Nos hemos mudado. Los productos Merck Millipore ya no pueden adquirirse en MerckMillipore.comMás información

MABE920 Anti-Mi-2β Antibody, clone 17H11

MABE920
100 µg  
Purchase on Sigma-Aldrich

Ofertas especiales

Descripción

Replacement Information

Ofertas especiales

Tabla espec. clave

Species ReactivityKey ApplicationsHostFormatAntibody Type
HWB, ChIP, ChIP-seqMAffinity PurifiedMonoclonal Antibody
Description
Catalogue NumberMABE920
DescriptionAnti-Mi-2β Antibody, clone 17H11
Alternate Names
  • Chromodomain-helicase-DNA-binding protein 4
  • CHD-4
  • ATP-dependent helicase CHD4
  • Mi-2 autoantigen 218 kDa protein
  • Mi2-beta
  • Mi-2b
Background InformationCHD-4, often referred to as Mi2-beta, is a central component of the nucleosome remodeling and histone deacetylase (NuRD) repressor complex. CHD-4 has been shown to interact with TRIM27, HDAC1, Histone deacetylase 2, MTA2, SATB1 and Ataxia telangiectasia and Rad3 related. This protein also interacts with KLF1. Sumoylation of KLF1 leads to transcriptional repression of CHD-4.
References
Product Information
FormatAffinity Purified
PresentationPurified mouse monoclonal IgG2bκ supernatant in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationThis Anti-Mi-2β Antibody, clone 17H11 is validated for use in Western Blotting and Chromatin Immunoprecipitation (ChIP) and ChIP-seq for the detection of Mi-2β.
Key Applications
  • Western Blotting
  • Chromatin Immunoprecipitation (ChIP)
  • ChIP-seq
Application NotesChromatin Immunoprecipitation (ChIP): A representative lot of this antibody as part of a monoclonal antibody cocktail was used for ChIP. See Zhang et al., 2012 for details.

ChIP-seq Analysis: A representative lot of this antibody as part of a monoclonal antibody cocktail was used for ChIP-seq. See Zhang et al., 2012 for details.
Biological Information
ImmunogenRecombinant protein corresponding to Human Mi-2β (CHD-4).
Clone17H11
ConcentrationPlease refer to lot specific datasheet.
HostMouse
SpecificityRecognizes Mi-2β (CHD-4)
IsotypeIgG2bκ
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Gene Symbol
  • CHD4
Purification MethodProtein G Purified
UniProt Number
Molecular Weight~ 220 kDa observed
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blotting in a Jurkat cell lystate.

Western Blotting Analysis: A 1 µg/mL dilution of this antibody detected Mi-2β (CHD-4) in a Jurkat cell lysate.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Número de referencia GTIN
MABE920 04055977073669

Documentation

Anti-Mi-2β Antibody, clone 17H11 Ficha datos de seguridad (MSDS)

Título

Ficha técnica de seguridad del material (MSDS) 

Anti-Mi-2β Antibody, clone 17H11 Certificados de análisis

CargoNúmero de lote
Anti-Mi-2β, clone 17H11 - Q2469322 Q2469322
Anti-Mi-2β, clone 17H11 - 3195423 3195423
Anti-Mi-2β, clone 17H11 Monoclonal Antibody 2959577

Referencias bibliográficas

Visión general referenciasPub Med ID
Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis.
Zhang, J; Jackson, AF; Naito, T; Dose, M; Seavitt, J; Liu, F; Heller, EJ; Kashiwagi, M; Yoshida, T; Gounari, F; Petrie, HT; Georgopoulos, K
Nature immunology  13  86-94  2011

Mostrar resumen
22080921 22080921